REPRESENT-PF Registry, Observational, PFA Atrial Fibrillation

NIH ClinicalTrials.gov published the REPRESENT-PF registry (NCT07535268), an observational study evaluating pulsed field ablation using Boston Scientific FARAWAVE catheters for atrial fibrillation in underrepresented minority patients. The registry is pragmatic, prospective, single-arm, and multi-center, collecting standard-of-care data to assess safety and effectiveness.

Healthcare providers and clinical investigators involved in cardiac arrhythmia treatment should note this registry as a potential source of post-market evidence on PFA technology in diverse patient populations. The study does not create compliance obligations but may inform future clinical practice and device labeling.